Search
Powered By HealthLine
Health Tools
 Mood Tracker
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

New Test Might 'Smell' Early Stage Lung Cancer

Mouse study suggests changes in scent of urine could catch disease quickly

By Alan Mozes
HealthDay Reporter


Related Encyclopedia
 border=
Adenocarcinoma of the Lung and Brain Metastases
Basal Cell Carcinoma
Bladder Cancer
Bone Cancer
More...

Related Healthscout Videos
 border=
Growing Lungs in the Lab: Medicine's Next Big Thing?
From Belly to Breast: Rebuilding After Cancer
Shaving off Cancer
Fluorescent Medicine for Brain Tumors
More...

Related Animations
 border=
Breast Self-Exam Video
Colon Cancer
More...

Related Drug Information
 border=
Epogen
Iressa
Procrit
Topamax
More...

Related News Articles
 border=
Damage of 'False-Positive' Mammograms Overlooked: Study
Smoking Scenes in Movies Light Up Smokers' Brains
Gene Test Might Predict Colon Cancer's Return
Breast Cancer Radiation Before 1984 Tied to Heart Disease
More...

WEDNESDAY, Jan. 27 (HealthDay News) -- Scientists say they have fashioned a new test that can detect lung cancer simply on the basis of a tumor-causing change in the odor of bodily fluids.

The finding is so far based solely on work with mice, but follow-up studies are underway to see if this novel approach could aid in the early diagnosis of lung cancer in humans.

Text Continues Below



"But this work already proves, at least in principle, that tumors -- in this case lung cancer tumors in mice -- result in a change in odors that ought to be useful for diagnostic purposes," observed senior study author Gary K. Beauchamp, a biologist at Monell Chemical Senses Center in Philadelphia.

Beauchamp and his colleagues published their findings online in the January issue of PLoS One.

The authors noted that lung cancer is the leading cause of cancer-related deaths worldwide. According to the American Cancer Society, nearly 220,000 men and women were diagnosed with lung cancer in the United States in 2009. Nearly 160,000 Americans died from the disease that same year.

Researchers have long sought to expand the ways they could screen for lung cancer at as early a stage as possible, given that the disease often develops in the absence of easily identifiable symptoms.

Although previous anecdotal reports have indicated that tumor-provoked odor changes might signal the presence of cancer, the research team noted that this prospect has never conclusively been proven.

Setting out to do just that, Beauchamp and his associates devised what they described as a "rigorously controlled animal model" to isolate smell biomarkers in the urine of mice that develop as the result of lung cancer-induced organic compound changes occurring at the molecular level.

On one front, the researchers trained so-called "sensor mice" to recognize the particular scent found in the urine of mice that had developed lung cancer tumors. These mice were ultimately able to tell the difference between mice with lung cancer and healthy mice.

Page:  1 | 2 | 3 | Next >>

Copyright © 2010 HealthDay. All rights reserved.
Last updated 1/27/2010

Related Links
 border=
From Healthscout's partner site on asthma, MyAsthmaCentral.com
VIDEO: Lung stents help asthmatics to breathe easier
TREATMENT: Medication and lifestyle changes provide asthma relief
DRUGS: Common drugs used to treat asthma




SOURCES: Gary K. Beauchamp, Ph.D., biologist, Monell Chemical Senses Center, Philadelphia; Roy Herbst, M.D., chief, section of thoracic medical oncology, department of Thoracic/Head and Neck Medical Oncology, M.D Anderson Cancer Center, Houston; Jan. 26, 2010, PLoS One, online


HealthScout is a part of HealthCentral
About Us   Our Blog   Contact Us   Privacy Policy   Terms of Use   Site Map  
Copyright © 2001-2011. The HealthCentralNetwork, Inc. All rights reserved.
Advertising Policy   Editorial Policy Advertise With Us   Anti-Spam Policy   PR Newswire